Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4, Cluster-Randomized Crossover, Prospective, Multi-Center Trial Evaluating the Safety of Freeze-Dried Plasma and Conventional Plasma Products in Adult Patients

NCT07840352 is registered in ClinicalTrials.gov with Teleflex as lead sponsor.

NCT NCT07840352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07840352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4, Cluster-Randomized Crossover, Prospective, Multi-Center Trial Evaluating the Safety of Freeze-Dried Plasma and Conventional Plasma Products in Adult Patients
Lead sponsor
Teleflex
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 31, 2027
Completion date
May 31, 2031
Enrollment
867 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

fdp, thromboembolic event